Just days before South African scientists were set to launch clinical trials of a promising HIV vaccine, their progress was abruptly halted. An email landed in their inboxes, brief and devastating: ...

This is what it looks like when disinformation doctors pretend to value data and science to further their true objective, ...

South Africa’s HIV vaccine project lost key funding days before launch, forcing labs to close, workers to be laid off, and ...

Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy ...

He stated that the episode of the last six months showed just how brutally efficient the price discovery process is, in any ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

Buying shares of beaten-down companies only makes sense if there are good reasons to expect them to bounce back. If that's not the case, stocks that may look cheap and attractive aren't actually so.

Pfizer's COVID vaccine (Comirnaty) is fully approved for patients ages 12 and up, and authorized for kids ages 6 months ...

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...

Unlike Drs. Adam Cifu and John Mandrola, I do not constantly boast of my "nuance" or claim to be a master of "clinical ...